Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma

BACKGROUND: Cytokine-induced killer (CIK) cell-based immunotherapy is effective as adjuvant therapy in early stage hepatocellular carcinoma (HCC) but lacks efficacy in advanced HCC. We investigated immune suppressor mechanisms focuing on CIKs and myeloid-derived suppressor cells (MDSCs). METHODS: MD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Hepatol
Main Authors: Yu, Su Jong, Ma, Chi, Heinrich, Bernd, Brown, Zachary J., Sandhu, Milan, Zhang, Qianfei, Fu, Qiong, Agdashian, David, Rosato, Umberto, Korangy, Firouzeh, Greten, Tim F.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380944/
https://ncbi.nlm.nih.gov/pubmed/30414862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2018.10.040
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados